Name: Addressing Viral Hepatitis in People With Substance Use Disorders: Treatment Improvement Protocol Series (TIP 53) (en Inglés)
Price: 142610.00 COP
Availability: InStock
Author: Services, U. S. Department of Health and
ISBN: 9781304183446

portada Addressing Viral Hepatitis in People With Substance Use Disorders: Treatment Improvement Protocol Series (TIP 53) (en Inglés)

Formato

Libro Físico

Autor

U. S. Department of Health and Services

Editorial

Lulu.com

Idioma

Inglés

N° páginas

146

Encuadernación

Tapa Blanda

Dimensiones

27.9 x 21.6 x 0.8 cm

Peso

0.35 kg.

ISBN13

9781304183446

Categorías

Ciencias matemáticas

Addressing Viral Hepatitis in People With Substance Use Disorders: Treatment Improvement Protocol Series (TIP 53) (en Inglés)

U. S. Department of Health and Services (Autor) · Lulu.com · Tapa Blanda

Libro Nuevo

$ 142.610

$ 219.400

Ahorras: $ 76.790

35% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 19 de Julio y el Martes 30 de Julio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Addressing Viral Hepatitis in People With Substance Use Disorders: Treatment Improvement Protocol Series (TIP 53) (en Inglés)"

Introduction: An estimated 3.5-5.3 million people in the United States live with chronic viral hepatitis (Institute of Medicine [IOM], 2010). Viral hepatitis is often a silent disease whose symptoms and signs become evident only after the disease has caused severe liver damage. The symptoms of hepatitis can take decades to manifest, so many people who are infected with hepatitis are unaware that they have the disease and therefore do not seek treatment. As a result, between 2010 and 2020, an estimated 150,000 people in the United States could die of liver cancer or other hepatitis-related liver disease (IOM, 2010). For many of these people, substance use will be a major factor that contributes to or worsens their hepatitis-related outcomes. All people who use or have used illicit substances are at risk of contracting viral hepatitis. Injection drug use (IDU) is the primary way of contracting hepatitis C, and people who use substances are at risk for contracting other forms of viral hepatitis.